Iguchi Kimi - Nov 22, 2021 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)

Role
CFO & Treasurer
Signature
/s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Kimi Iguchi
Stock symbol
SAGE
Transactions as of
Nov 22, 2021
Transactions value $
$4,760
Form type
4
Date filed
11/23/2021, 04:15 PM
Previous filing
Oct 21, 2021
Next filing
Feb 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SAGE Common Stock Options Exercise $3.4K +2.5K +5.25% $1.36 50.1K Nov 22, 2021 Direct
transaction SAGE Common Stock Options Exercise $1.36K +1K +2% $1.36 51.1K Nov 23, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SAGE Stock Option (Right to Buy) Options Exercise $0 -2.5K -83.47% $0.00 495 Nov 22, 2021 Common Stock 2.5K $1.36 Direct F1
transaction SAGE Stock Option (Right to Buy) Options Exercise $0 -495 -100% $0.00* 0 Nov 23, 2021 Common Stock 495 $1.36 Direct F1
transaction SAGE Stock Option (Right to Buy) Options Exercise $0 -505 -3.6% $0.00 13.5K Nov 23, 2021 Common Stock 505 $1.36 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2011 Stock Option and Incentive Plan. The option vested in full on March 12, 2016.
F2 The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2011 Stock Option and Incentive Plan. The option vested in full on July 23, 2016.